There were many kinds of genomic aberrations observed in lung cancer patients, including epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) rearrangement, which are the most well known genetic alterations6, 7. Here, ALK is linked to lung carcinoma.